URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Kevin Walter

Concepts (205)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Brain Neoplasms
15
1994
281
3.550
Why?
Glioma
7
1994
102
2.330
Why?
Gene Expression Regulation, Neoplastic
3
2005
256
1.200
Why?
Neovascularization, Pathologic
3
2004
96
1.120
Why?
Glioblastoma
6
2000
63
1.110
Why?
Carrier Proteins
3
2005
426
1.000
Why?
Membrane Proteins
3
2005
540
0.980
Why?
Endothelium, Vascular
3
2004
406
0.950
Why?
Tumor Markers, Biological
3
2004
229
0.900
Why?
Paclitaxel
4
1994
58
0.860
Why?
Blood-Brain Barrier
3
2003
108
0.810
Why?
Collagen
2
2005
290
0.750
Why?
Hematoma, Subdural, Acute
1
2010
1
0.720
Why?
Decompressive Craniectomy
1
2010
1
0.720
Why?
Matrix Metalloproteinase 14
1
2010
12
0.710
Why?
Spinal Cord Neoplasms
1
2009
22
0.690
Why?
SEER Program
1
2009
53
0.690
Why?
Antigens, Neoplasm
1
2009
106
0.660
Why?
Antigens, CD
1
2009
244
0.620
Why?
Magnesium Sulfate
1
2007
11
0.610
Why?
Brain Ischemia
1
2008
86
0.580
Why?
Magnesium
1
2007
131
0.580
Why?
Drug Delivery Systems
2
2003
59
0.560
Why?
Anticonvulsants
1
2007
122
0.540
Why?
Brain Injuries
1
2007
106
0.530
Why?
Hepatocyte Growth Factor
2
2000
13
0.510
Why?
Microspheres
2
2003
56
0.490
Why?
Biocompatible Materials
2
2003
63
0.470
Why?
Central Nervous System Neoplasms
1
2003
22
0.450
Why?
Radiosurgery
3
2000
74
0.420
Why?
CDC2-CDC28 Kinases
1
2002
10
0.420
Why?
Proto-Oncogene Proteins c-myc
1
2002
47
0.410
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2005
542
0.380
Why?
Cell Cycle
1
2002
254
0.370
Why?
Humans
25
1994
36274
0.360
Why?
Retrospective Studies
7
1995
2267
0.310
Why?
Treatment Outcome
7
1995
2615
0.290
Why?
In Situ Hybridization
2
2005
323
0.290
Why?
DNA-Binding Proteins
1
2002
685
0.280
Why?
Male
14
1994
19675
0.270
Why?
RNA, Messenger
3
2004
1863
0.260
Why?
Up-Regulation
2
2005
363
0.250
Why?
Glasgow Coma Scale
3
1997
52
0.240
Why?
Aged
9
2000
7269
0.240
Why?
Tissue Array Analysis
2
2009
35
0.220
Why?
Aged, 80 and over
6
2000
2529
0.220
Why?
Middle Aged
9
2000
9837
0.210
Why?
Female
10
2000
19838
0.210
Why?
Kaplan-Meier Estimate
2
2009
222
0.210
Why?
Adult
9
2000
11351
0.200
Why?
Cell Line, Tumor
2
2003
575
0.200
Why?
Brain
4
1994
1214
0.200
Why?
Animals
8
1994
16093
0.200
Why?
Vimentin
1
2011
28
0.200
Why?
Carcinoma, Pancreatic Ductal
1
2011
14
0.190
Why?
Adolescent
3
2007
4766
0.190
Why?
Rats, Inbred F344
3
1994
360
0.190
Why?
Analysis of Variance
3
2000
736
0.180
Why?
Pancreatic Neoplasms
1
2011
82
0.180
Why?
Receptors, CXCR
1
2010
4
0.180
Why?
Aortic Valve Stenosis
1
2010
21
0.180
Why?
Peroxidase
1
2010
36
0.180
Why?
Central Nervous System
1
2011
113
0.180
Why?
Dacarbazine
1
2010
21
0.180
Why?
Antineoplastic Agents
1
1995
619
0.180
Why?
Xenograft Model Antitumor Assays
1
2009
47
0.180
Why?
Antineoplastic Agents, Alkylating
1
2010
42
0.180
Why?
Immunohistochemistry
2
2009
1064
0.170
Why?
Transcription, Genetic
2
2002
812
0.170
Why?
Extracellular Matrix Proteins
1
2010
74
0.170
Why?
Culture Media, Conditioned
2
2005
62
0.170
Why?
Reoperation
1
2010
183
0.170
Why?
Mice, Nude
1
2009
183
0.170
Why?
Fluorescent Antibody Technique
1
2009
283
0.170
Why?
Catheterization
1
2010
125
0.170
Why?
Protein-Serine-Threonine Kinases
2
2000
276
0.160
Why?
Chi-Square Distribution
1
2010
344
0.160
Why?
Survival Analysis
6
1994
606
0.160
Why?
Aneurysm, Ruptured
2
1997
9
0.150
Why?
Gene Expression
2
2000
751
0.150
Why?
Neoplasm Recurrence, Local
1
2010
288
0.150
Why?
Cancer Vaccines
1
2007
33
0.150
Why?
Subarachnoid Hemorrhage
2
1997
28
0.150
Why?
Fibroblasts
2
2007
534
0.150
Why?
Tumor Cells, Cultured
4
1994
881
0.150
Why?
Mice
2
2008
6111
0.150
Why?
Species Specificity
1
2008
341
0.150
Why?
Infant
2
2009
2278
0.150
Why?
Interleukin-4
1
2007
163
0.140
Why?
Databases, Factual
1
2007
156
0.140
Why?
Cell Movement
2
2005
361
0.140
Why?
Child, Preschool
2
2009
2660
0.140
Why?
Mice, Knockout
1
2009
895
0.140
Why?
Age Factors
1
2009
1128
0.140
Why?
Laminin
1
2005
45
0.130
Why?
Antineoplastic Agents, Phytogenic
1
2006
40
0.130
Why?
Microcirculation
1
2005
92
0.130
Why?
Proteoglycans
1
2005
100
0.130
Why?
Drug Combinations
1
2005
148
0.130
Why?
Drug Implants
2
1994
18
0.130
Why?
RNA Interference
1
2005
131
0.130
Why?
Ischemia
1
2005
87
0.130
Why?
Biological Markers
1
2008
560
0.130
Why?
Young Adult
1
2009
1059
0.120
Why?
Neoplasm Metastasis
1
2005
228
0.120
Why?
RNA, Small Interfering
1
2005
192
0.120
Why?
Rats
4
1994
4289
0.120
Why?
Transfection
1
2007
859
0.120
Why?
Vascular Endothelial Growth Factor A
1
2005
203
0.120
Why?
Child
2
2009
4155
0.120
Why?
Cohort Studies
1
2007
969
0.120
Why?
Disease Models, Animal
1
2008
956
0.110
Why?
Karnofsky Performance Status
2
2000
14
0.110
Why?
Blotting, Western
1
2005
645
0.110
Why?
Chromatography, High Pressure Liquid
1
2003
208
0.110
Why?
Time Factors
3
2000
3182
0.110
Why?
Contact Inhibition
1
2002
4
0.110
Why?
E2F1 Transcription Factor
1
2002
4
0.110
Why?
E2F Transcription Factors
1
2002
4
0.110
Why?
Cyclin-Dependent Kinase 2
1
2002
11
0.110
Why?
Mice, Inbred C57BL
1
2008
1675
0.110
Why?
Cyclin-Dependent Kinase Inhibitor p27
1
2002
33
0.100
Why?
S Phase
1
2002
47
0.100
Why?
G1 Phase
1
2002
52
0.100
Why?
Cyclin-Dependent Kinases
1
2002
40
0.100
Why?
Proportional Hazards Models
1
2003
450
0.100
Why?
Culture Media
1
2002
195
0.100
Why?
RNA
1
2005
397
0.100
Why?
Active Transport, Cell Nucleus
1
2002
96
0.100
Why?
Tumor Suppressor Proteins
1
2002
89
0.100
Why?
Cranial Irradiation
1
2000
14
0.100
Why?
Dose Fractionation
3
2000
60
0.090
Why?
Recombinant Fusion Proteins
1
2002
382
0.090
Why?
Cell Cycle Proteins
1
2002
160
0.090
Why?
Carcinoma, Non-Small-Cell Lung
1
2000
72
0.090
Why?
Phosphatidylinositol 3-Kinases
1
2000
157
0.080
Why?
Cells, Cultured
1
2005
2479
0.080
Why?
Inflammation
1
2003
534
0.080
Why?
Radiotherapy Dosage
3
1995
203
0.080
Why?
Patient Selection
1
2000
212
0.080
Why?
Proto-Oncogene Proteins
1
2000
289
0.080
Why?
Intracranial Aneurysm
1
1997
21
0.070
Why?
Combined Modality Therapy
2
2007
486
0.070
Why?
Neurologic Examination
1
1997
146
0.070
Why?
Lung Neoplasms
1
2000
439
0.070
Why?
Prognosis
3
1997
1083
0.070
Why?
Transcription Factors
1
2002
687
0.070
Why?
Infusion Pumps, Implantable
1
1995
8
0.070
Why?
Injections, Intralesional
1
1995
13
0.070
Why?
Decanoic Acids
1
1994
5
0.060
Why?
Polyesters
1
1994
6
0.060
Why?
Clinical Trials, Phase II as Topic
1
1994
13
0.060
Why?
Biopolymers
1
1994
11
0.060
Why?
Apoptosis
1
2000
823
0.060
Why?
Tissue Distribution
1
1994
236
0.060
Why?
Dose-Response Relationship, Drug
1
1995
1117
0.050
Why?
Clinical Trials as Topic
1
1995
671
0.050
Why?
Pancreatectomy
1
2011
18
0.050
Why?
Signal Transduction
1
2000
1567
0.050
Why?
Prospective Studies
3
1997
1689
0.050
Why?
Follow-Up Studies
2
2000
1855
0.050
Why?
Epithelium
1
2011
228
0.050
Why?
Salvage Therapy
1
2009
59
0.040
Why?
Disease-Free Survival
1
2009
198
0.040
Why?
Dose-Response Relationship, Radiation
2
1995
219
0.040
Why?
Pseudopodia
1
2007
10
0.040
Why?
Feasibility Studies
1
2007
202
0.040
Why?
Neoplasm Invasiveness
1
2007
155
0.040
Why?
Survival
1
2006
4
0.030
Why?
Chemistry, Pharmaceutical
1
2006
22
0.030
Why?
Microscopy, Fluorescence
1
2007
264
0.030
Why?
Cell Communication
1
2007
139
0.030
Why?
Dogs
1
2006
468
0.030
Why?
Infant, Newborn
1
2010
1844
0.030
Why?
Magnetic Resonance Imaging
1
2010
991
0.030
Why?
Cell Proliferation
1
2007
515
0.030
Why?
Ribonucleoprotein, U1 Small Nuclear
1
2000
2
0.020
Why?
Gliosarcoma
1
2000
4
0.020
Why?
Esophagitis
1
2000
8
0.020
Why?
Proto-Oncogene Proteins c-met
1
2000
16
0.020
Why?
Radiation Pneumonitis
1
2000
44
0.020
Why?
Proto-Oncogene Proteins c-akt
1
2000
128
0.020
Why?
RNA, Catalytic
1
2000
58
0.020
Why?
Gene Transfer Techniques
1
2000
147
0.020
Why?
Neoplasm Staging
1
2000
338
0.020
Why?
Protein-Tyrosine Kinases
1
2000
170
0.020
Why?
Regression Analysis
1
2000
527
0.020
Why?
Carcinoma, Squamous Cell
1
2000
236
0.020
Why?
Palliative Care
1
2000
159
0.020
Why?
Survival Rate
1
2000
618
0.020
Why?
Recombinant Proteins
1
2000
723
0.020
Why?
Craniotomy
1
1997
17
0.020
Why?
Adenocarcinoma
1
2000
439
0.020
Why?
Confidence Intervals
1
1997
165
0.020
Why?
Matched-Pair Analysis
1
1995
17
0.020
Why?
Length of Stay
1
1997
287
0.020
Why?
Remission Induction
1
1995
161
0.020
Why?
Prevalence
1
1997
562
0.020
Why?
Predictive Value of Tests
1
1997
606
0.020
Why?
Incidence
1
1997
685
0.020
Why?
Tumor Stem Cell Assay
1
1994
24
0.010
Why?
Medulloblastoma
1
1994
20
0.010
Why?
Cerebellar Neoplasms
1
1994
23
0.010
Why?
Severity of Illness Index
1
1997
922
0.010
Why?
Risk Factors
1
1997
2345
0.010
Why?

Visualizations


Walter's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department